Peter Barrett, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 91,500 shares at $15.14 ($1.4M) on 2006-02-23, disclosed to the SEC on 2006-02-27.
Open-market sale of $1.4M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.14 | 166 | $3K | 0.2% |
| 2 | $15.14 | 331 | $5K | 0.4% |
| 3 | $15.14 | 488 | $7K | 0.5% |
| 4 | $15.14 | 2,474 | $37K | 2.7% |
| 5 | $15.14 | 9,960 | $151K | 11.0% |
| 6 | $15.14 | 18,081 |
| $274K |
| 20.1% |
| 7 | $14.80 | 316 | $5K | 0.3% |
| 8 | $14.80 | 631 | $9K | 0.7% |
| 9 | $14.80 | 930 | $14K | 1.0% |
| 10 | $14.80 | 4,713 | $70K | 5.1% |
| 11 | $14.80 | 18,971 | $281K | 20.6% |
| 12 | $14.80 | 34,439 | $510K | 37.3% |
| Total | $14.92 avg | 91,500 | $1.4M | 100% |
| Filing → |
| PKI | SELL | 2017-11-14 | $1.0M | — | Filing → |
| PKI | SELL | 2017-06-02 | $632K | — | Filing → |
| VTAE | BUY | 2014-10-01 | $300K | — | Filing → |